Skip to content

MDMA: all studies

Page 253 of 346: studies 2,521 to 2,530 of 3,454, newest first. Back to the MDMA overview

Research

The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences.

Journal of Psychopharmacology May 1, 2026 Vincent J Diehl, Abigail E. Calder, Gregor Hasler

Existing tools assess psychedelic experiences, but none specifically measure altered processing of traumatic memories-a key mechanism in trauma-focused therapies and psychotherapy in general. The helioscope effect describes how psychedelics like psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) enable revisiting challenging or traumatic experiences while remaining protected from...

Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health.

Drug and Alcohol Dependence May 1, 2026 Juan Carlos C. Montoy, Ralph C. Wang, Allison R. Coker et al.

Psychedelic drug use is increasing due in part to local legislative reforms. Understanding the patterns of first-time psychedelic drug use is imperative for informing consumers, healthcare providers, and policy makers. The National Survey on Drug Use and Health (NSDUH) is a repeated cross-sectional nationally representative survey of civilians aged 12 and older. Use estimates are presented for...

Psychological support in psychedelic-assisted therapy clinical trials: A systematic review.

Journal of Psychopharmacology May 1, 2026 Bonnie Brusky, Katia M'Bailara, François Alla et al.

The nature and role of the psychological support provided in psychedelic-assisted treatments for psychiatric disorders are currently the object of debate. How this support is conceptualized-as a vector for therapeutic change or framework for risk minimization-has far-reaching consequences in terms of how these treatments should be regulated, delivered, and studied. To determine whether...

Methylone demonstrates improvement in PTSD symptoms in Phase 2 study

The Brown University Psychopharmacology Update April 30, 2026

Four weekly doses of TSND‐201 (methylone), an analog of 3,4 methylenedioxymethamphetamine (MDMA), resulted in significant improvement relative to placebo in reducing symptoms of post‐traumatic stress disorder (PTSD), a Phase 2 study has found. Treatment‐emergent adverse events associated with TSND‐201 were generally mild to moderate in severity, with no significant suicidal ideation. Study...

DOI: 10.1002/pu.31448 (opens in new tab) Placebo Adverse effect Phase matter Posttraumatic stress +1

Psychedelics and Autism Therapy: A Review of Current Research and Future Directions

Current Issues in Molecular Biology April 18, 2026 Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi et al.

Autism Spectrum Disorder (ASD) is a lifelong condition marked by challenges in social communication and repetitive behaviors. Current treatments, primarily behavioral therapies, often fail to address the core symptoms. Recent research has explored the potential of psychedelics, such as LSD, psilocybin, and MDMA, as a new therapeutic approach. While these substances primarily modulate the...

DOI: 10.3390/cimb48040417 (opens in new tab) Neuroplasticity Glutamatergic Autism spectrum disorder Therapeutic approach +2

Cross-species metabolic characterization of eutylone and mechanism-based inhibition of CYP2D6 and CYP2B6 with drug interaction implications.

Scientific Reports April 16, 2026 Min Seo Lee, Im-Sook Song, Yeonsu Jang et al.

Eutylone is a methylenedioxy-substituted synthetic cathinone increasingly detected in toxicological case analyses and commonly encountered under polydrug use conditions. To support metabolism-informed surveillance and risk assessment of emerging stimulants, this study comprehensively characterized eutylone disposition and interaction liability using plasma protein binding, metabolic stability...

DOI: 10.1038/s41598-026-48814-7 (opens in new tab) Full text (opens in new tab) Cyp Drug-drug interaction Eutylone Metabolism +1

Deus é liberdade: tópicos de teologia fundamental de inspiração místico-ontológica

Revista Pistis & Praxis April 15, 2026 Fernando Rodrigues

Partindo da tese de que “Deus é liberdade”, este artigo desenvolve uma teologia fundamental de cunho místico-especulativo, em diálogo com a ontologia heideggeriana da transcendência e a mística trinitária de Mestre Eckhart. Argumenta-se que a liberdade, mais do que faculdade subjetiva, é estrutura ontológica de doação: êxtase que funda o ser, a Trindade e a relação. Por meio do método da...

Blinding Integrity in Psychedelic Randomized Clinical Trials

JAMA Psychiatry April 15, 2026 Diana Orsini, Sabrina Wong, Sara Di Luch et al. 4 citations

Importance: Psychedelic drugs possess acute psychoactive effects that can compromise blinding integrity in randomized clinical trials (RCTs). Functional unblinding, when participants or raters correctly identify treatment allocation based on subjective effects, may bias outcomes through expectancy effects, challenging the validity of efficacy estimates and regulatory acceptance. Objective: To...

DOI: 10.1001/jamapsychiatry.2026.0255 (opens in new tab) Blinding Randomized controlled trial Clinical trial Meta-analysis +4

Form of transcendence in sports. Suggestion from Hollywood

DOAJ (DOAJ: Directory of Open Access Journals) April 10, 2026 Nicola Strizzolo, Nico Bortoletto

This paper examines how lifestyle sport practitioners experience forms of transcendence, altered perception, and connection with nature, and considers whether these experiences can be meaningfully interpreted through concepts associated with shamanic practice. Drawing on Roger Caillois’ taxonomy, it explores how elements of ritual, ecstasy, and symbolic imagination appear within contemporary...

DOI: 10.6093/2611-6693/13463 (opens in new tab) Shamanism Parallels Transcendence philosophy Attunement +18

Persona y ambiente: una revisión narrativa sobre la importancia del contexto en la terapia asistida con psicodélicos

Vertex Revista Argentina de Psiquiatría April 10, 2026 Daniel Arroyo-Zúñiga, Javeth Calvo-Molina, José Manuel Rodríguez-arce

Este artículo presenta una revisión narrativa sobre las variables extrafarmacológicas que influyen en la terapia asistida con psicodélicos (TAPs). A partir del análisis de literatura reciente, se destaca la importancia de la persona (set) y el ambiente (setting) en la modulación de los efectos subjetivos y terapéuticos de sustancias como la psilocibina o el MDMA. El objetivo principal fue...

DOI: 10.53680/vertex.v37i171.978 (opens in new tab) Context archaeology Persona Perspective graphical Product mathematics +1